Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 20,158

Document Document Title
WO/2018/007479A1
The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to...  
WO/2018/008737A1
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...  
WO/2018/004095A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004187A1
The present invention provides a novel compound capable of improving light-emitting efficiency, stability, and life span of an element, an organic electrical element using the same, and an electronic device therefor.  
WO/2018/004096A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2017/220925A1
The invention relates to a method for preparing substituted thiolactones of formula (I), new substituted thiolactones of formula (I') that can be obtained by carrying out said method, and the use of substituted thiolactones of formula (I...  
WO/2017/221780A1
Provided is a photoelectric conversion element having superior durability against irradiation with light. The photoelectric conversion element has a cathode, an anode, an active layer provided between the cathode and the anode and contai...  
WO/2017/223407A1
The present invention is a conjugated polymer that contains both Unit (I) and Unit (II) is shown below: X, in each occurrence, is independently selected from S or Se. M1 and M2 are independently selected from H or F. R1 and R2 are indepe...  
WO/2017/217553A1
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] An oxime compound represented by formula (1) and an herbicide containing the same. (In formula (1): B represents B-1 or the like; Q represents ...  
WO/2017/217676A1
The present invention relates to a novel compound having excellent thermal stability and luminescent ability, and an organic electroluminescent element having enhanced characteristics such as luminous efficiency, driving voltage, and lif...  
WO/2017/216661A1
The present invention relates to a process for the preparation of 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy} quinolin-2(1H)-one (brexpiprazole) from 7-(4-chlorobutoxy)quinolin-2(1H)-one and 1-(benzo[b]thiophen-4-yl)piperazine. ...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/209294A1
According to the present invention, it is possible to safely and easily obtain sulfonimidized aromatic compounds using various substrates and a novel sulfonimidization agent by irradiating, with light in the presence of an oxidizer, a co...  
WO/2017/208965A1
The present invention provides an organic compound characterized by being represented by general formula [1] set forth in the claims. In general formula [1], Ar1 and Ar2 are each independently selected from among aryl groups having 6-18 ...  
WO/2017/207596A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.  
WO/2017/208251A1
The present invention relates to a new crystalline polymorph of brexpiprazole. More specifically, the invention relates to novel Form M of brexpiprazole, process for preparing the novel form of brexpiprazole and pharmaceutical formulatio...  
WO/2017/209322A1
The present invention relates to a five-membered heterocyclic compound having an analgesic effect and a pharmaceutical composition comprising a derivative of the five-membered heterocyclic compound. More specifically, the present inventi...  
WO/2017/209297A1
A compound represented by general formula (2) [wherein R1 and R2 are as defined above; and X represents a halogen atom] is reacted in the presence of a palladium catalyst and a base. In this manner, it becomes possible to synthesize a tr...  
WO/2017/204556A1
Provided are an organic electronic element and an electronic device therefor, the organic electronic element having a mixture of a compound according to the present invention used as material for an organic layer thereof, thereby enablin...  
WO/2017/204144A1
Provided is a method for amidating a hydroxy ester compound at a high chemical selectivity. The amidation reaction method for a hydroxy ester compound comprises, in the presence of a catalyst containing a compound of a transition metal o...  
WO/2017/204557A1
Provided are an organic electronic element and an electronic device therefor, the organic electronic element having a mixture of a compound according to the present invention used as a material therefor, thereby enabling the achievement ...  
WO/2017/202340A1
Disclosed are a series of photoisomeric compounds, preparation method therefor and devices comprising the compounds, wherein a photoisomeric compound-graphene molecular junction device is formed by linking the photoisomeric compound to a...  
WO/2017/197670A1
Disclosed in the present application is a method for synthesizing a 1,2-dimethylene cyclobutane chiral compound. The 1,2-dimethylene cyclobutane chiral compound is synthesized from an allenylamine compound in the presence of a rhodium co...  
WO/2017/196081A1
This invention provides a compound for an organic electroluminescent device and an organic electroluminescent device including the same. This invention provides a compound for an organic EL device, which may have high thermal stability, ...  
WO/2017/192304A1
The present disclosure is directed to compounds of formula (I): or a pharmaceutically acceptable salt, solvate or solvate of the salt thereof. Compounds of formula (I) are inhibitors of NOX4 and are useful in the treatment of fibrotic di...  
WO/2017/191896A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By using the organic electroluminescent compound of the present disclosure, an organic electroluminesc...  
WO/2017/188598A1
The present invention relates to a novel compound having excellent luminance performance and to an organic electroluminescent element having improved characteristics, such as luminous efficiency, driving voltage, and lifetime, by compris...  
WO/2017/188597A1
The present invention relates to a novel compound and an organic electroluminescent device comprising the same and, more specifically, to: a novel carbazole-based compound having excellent thermal stability, phosphorescence characteristi...  
WO/2017/184623A1
In one aspect, compounds of Formulae (I) and (II), or pharmaceutically acceptable salts thereof, are featured: Formulae (I) and (II), wherein the variables shown in Formulae (I) and (II) can be as defined anywhere herein.  
WO/2017/184624A1
In one aspect, compounds of Formulae (I) and (II), or pharmaceutically acceptable salts thereof, are featured; Formula (I), Formula (II) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formulae (I) and (II) ...  
WO/2017/184604A1
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2017/181004A1
The disclosure of a compound of Formula (I) or a pharmaceutically acceptable salt thereof (I) The variables W, R1, R2, R3, and R4 are defined in the disclosure. The disclosure provides a compound or salt of Formula (I) together with a ph...  
WO/2017/179926A1
The present invention relates to a novel benzothiophene derivative, a pharmaceutically acceptable salt thereof or an optical isomer thereof, a method for preparing same, and a pharmaceutical composition, containing same as an active ingr...  
WO/2017/173544A1
A method for treating and/or preventing VacA+ H. pylori infection and a disorder associated with VacA+ H. pylori infection is provided. The method comprises the administration of TRPML agonists such as ML-SA1, SF-22, SF-51, MK6-83 and th...  
WO/2017/171420A1
The present specification provides a compound of chemical formula 1 and an organic light emitting element comprising the same.  
WO/2017/171234A1
The present invention relates to: a novel compound having an excellent light-emitting ability; and an organic electroluminescent element having characteristics, which are improved, such as light-emitting efficiency, driving voltage, and ...  
WO/2017/168303A1
The present invention is directed to reaction mixtures comprising a water-surfactant mixture and a co-solvent. This technology reduced the amount of organic solvents needed for performing chemical reactions. Furthermore, compared to reac...  
WO/2017/170850A1
Provided is a method for industrially producing 5-(bromomethyl)-1-benzothiophene. The production method according to the present invention comprises: (1) a step for introducing 5-methyl-1-benzothiophene, a brominating agent, and a solven...  
WO/2017/170826A1
The purpose of the invention is to provide a compound useful in the prevention or treatment of diabetes, obesity, and conditions related thereto. The present invention relates to an enhancing agent for glucagon-like peptide-1 receptor ac...  
WO/2017/165356A1
Provided herein are processes for the preparation of heteroaryl carboxylic acids.  
WO/2017/153952A1
The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. ...  
WO/2017/153731A1
A compound of formula (I) wherein Z is a group of formula (II) and Core is selected from groups of formula (IIIa) or (IIIb) wherein X is S or O; R1 is a substituent; n is 0 or a positive integer; Ar1 independently in each occurrence is a...  
WO/2017/153789A1
The present invention relates to benzo[b]thiophene derivatives of general formula (I) and pharmaceutically acceptable salts, solvates, hydrates, stereoisomeric and polymorphic forms thereof wherein R1 is selected from the group of hydrog...  
WO/2017/148455A1
The invention relates to iodinated aromatic choline analogs of general formula wherein at least one R is iodine; the quaternary ammonium group comprises a hydroxyl substituent, and further substituent are as defined in the claims. The co...  
WO/2017/151625A1
The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and in...  
WO/2017/151625A8
The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and in...  
WO/2017/146405A1
Disclosed are an organic electronic element and an electronic device including the same, the organic electronic element comprising: a compound represented by chemical formula 1; a first electrode; a second electrode; and an organic layer...  
WO/2017/144863A1
A compound of formula (I) or (III) (Formulae (I), (III)) wherein: one Y is a substituent R1 bound directly to the fluorene unit of formula (I) by an sp3-hybridised carbon atom; the other Y is an aryl or heteroaryl group Ar1 that may be u...  
WO/2017/144150A2
The present invention relates to a process to produce compounds of the formula (1) which are suitable for use in electronic devices, as well as to intermediate compounds of formula (lnt-1) and compounds of formula (1-1) and (1-2) obtaine...  
WO/2017/146474A1
The present specification relates to a heterocyclic compound and an organic light emitting diode containing same.  

Matches 1 - 50 out of 20,158